1.Li, H and Cao, B (2017) Pandemic and avian influenza A viruses in humans: epidemiology, virology, clinical characteristics, and treatment strategy. Clinics in Chest Medicine 38, 59.
2.Quang, VT et al. (2017) Social and economic burden of patients with influenza-like illness and clinically diagnosed flu treated at various health facilities in Vietnam. ClinicoEconomics & Outcomes Research 9, 423.
3.Gianino, MM et al. (2017) Estimation of sickness absenteeism among Italian healthcare workers during seasonal influenza epidemics. PLoS ONE 12, e0182510.
4.Wu, S et al. (2018) Mortality burden from seasonal influenza and 2009 H1N1 pandemic influenza in Beijing, China, 2007–2013. Influenza & Other Respiratory Viruses 12(1).
6.Fineberg, HV (2014) Pandemic preparedness and response – lessons from the H1N1 influenza of 2009. New England Journal of Medicine 370, 1335.
7.Dawood, FS et al. (2012) Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infectious Diseases 12, 687–695.
8.Huang, IC et al. (2011) IFITM proteins mediate the innate immune response to influenza A H1N1 virus, West Nile virus and dengue virus. Cell 139, 1243.
9.Huang, IC et al. (2011) Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathogens 7, e1001258.
10.Li, K et al. (2013) IFITM proteins restrict viral membrane hemifusion. PLoS Pathogens 9, e1003124.
11.Desai, TM et al. (2014) IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion. PLoS Pathogens 10, e1004048.
12.Feeley, EM et al. (2011) IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathogens 7, e1002337.
13.Bailey, CC et al. (2012) Ifitm3 limits the severity of acute influenza in mice. PLoS Pathogens 8, e1002909.
14.Williams, DEJ et al. (2014) IFITM3 polymorphism rs12252-C restricts influenza A viruses. PLoS ONE 9, e110096.
15.Xuan, Y et al. (2015) IFITM3 rs12252 T>C polymorphism is associated with the risk of severe influenza: a meta-analysis. Epidemiology & Infection 143, 2975–2984.
16.Yang, X et al. (2015) Interferon-inducible transmembrane protein 3 genetic variant rs12252 and influenza susceptibility and severity: a meta-analysis. PLoS ONE 10, e0124985.
17.Everitt, AR et al. (2012) IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484, 519–523.
18.Mills, TC et al. (2014) IFITM3 and susceptibility to respiratory viral infections in the community. Journal of Infectious Diseases 209, 1028.
19.López-Rodríguez, M et al. (2016) IFITM3 and severe influenza virus infection. No evidence of genetic association. European Journal of Clinical Microbiology 35, 1811–11817.
20.Randolph, AG et al. (2017) Evaluation of IFITM3 rs12252 association with severe pediatric influenza infection. Journal of Infectious Diseases 216, 14.
21.Lee, N et al. (2017) IFITM3, TLR3, and CD55 genes SNPs and cumulative Ge-netic risks for severe outcomes in Chinese patients with H7N9/H1N1pdm09 influenza. Journal of Infectious Diseases 216, 97.
22.Pan, Y et al. (2017) IFITM3 Rs12252-C variant increases potential risk for severe influenza virus infection in Chinese population. Frontiers in Cellular & Infection Microbiology 7, 294.
23.Wang, Z et al. (2014) Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proceedings of the National Academy of Sciences of the USA 111, 769–774.
24.Zhang, YH et al. (2013) Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nature Communications 4, 1418.
25.David, S et al. (2017) Population genetics of IFITM3 in Portugal and Central Africa reveals a potential modifier of influenza severity. Immunogenetics 70, 1–9.
27.Molinari, NA et al. (2007) The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25, 5086.
28.Kenney, AD et al. (2017) Human genetic determinants of viral diseases. Annual Review of Genetics 51(1).
29.Ciancanelli, MJ et al. (2016) Host genetics of severe influenza: from mouse Mx1 to human IRF7. Current Opinion in Immunology 38, 109–120.